IDEAYA Biosciences
IDYA
68 hedge funds and large institutions have $236M invested in IDEAYA Biosciences in 2020 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 26 increasing their positions, 14 reducing their positions, and 12 closing their positions.
86% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 14
33% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 12
6% more funds holding
Funds holding: 64 → 68 (+4)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
1.65% less ownership
Funds ownership: 68.24% → 66.59% (-1.6%)
10% less capital invested
Capital invested by funds: $262M → $236M (-$26.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$4.11M |
| 2 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
+$2.39M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.39M |
| 4 |
BlackRock
New York
|
+$2.05M |
| 5 |
Two Sigma Investments
New York
|
+$1.96M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$3.52M |
| 2 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$3.47M |
| 3 |
AG
Artal Group
Luxembourg
|
-$2.96M |
| 4 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$1.99M |
| 5 |
Goldman Sachs
New York
|
-$1.83M |
IDYA Hedge Fund Activity: Q3 2020 in Review
68 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in IDEAYA Biosciences (IDYA) for Q3 2020, worth a combined $236M — down 10% from $262M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new IDYA positions and 12 closed out — a net gain of 4 holders — while 26 added to existing stakes and 14 trimmed.
The largest buyer was DAFNA Capital Management, opening a new position worth an estimated $4.11M. The largest seller was Citadel Advisors, exiting entirely with an estimated $3.52M sold.
- 68 institutional investors held IDEAYA Biosciences (IDYA) as of Q3 2020, up from 64 in Q2 2020.
- Funds reported $236M of IDEAYA Biosciences stock for Q3 2020, down 10% quarter-over-quarter.
- 16 funds opened new IDEAYA Biosciences positions in Q3 2020 and 12 closed out, a net change of +4 holders.
- The largest IDEAYA Biosciences buyer in Q3 2020 was DAFNA Capital Management, an estimated $4.11M added.
- The largest IDEAYA Biosciences seller in Q3 2020 was Citadel Advisors, an estimated $3.52M sold.
Based on aggregated 13F filings for Q3 2020.